TP53 and breast carcinoma: A previous described connection between the expression of RAI3 and an alteration of p53 in breast carcinoma cell lines [25] could not be confirmed, since cell lines with a high GPRC5A mRNA expression like PaCaDD 161 are p53 wild type and cell lines with a p53 mutation like BxPC3 display low GPRC5A level.